PDCD1 and cancer: Transcriptome and flow cytometric analysis of longitudinal melanoma biopsies collected from patients receiving PD-1 inhibitors identified downregulation of MHC-I to also be associated with TGFβ activity, SNAI1 upregulation, and cancer associated fibroblasts (78).